Drug Shortage Report for SEROQUEL XR
Report ID | 2471 |
Drug Identification Number | 02300206 |
Brand name | SEROQUEL XR |
Common or Proper name | quetiapine fumarate extended-release tablets |
Company Name | ASTRAZENECA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60 tablets |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-04-24 |
Actual start date | 2017-04-24 |
Estimated end date | 2017-04-26 |
Actual end date | 2017-04-26 |
Shortage status | Resolved |
Updated date | 2017-04-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-14 | English | Compare |
v2 | 2017-04-06 | English | Compare |
v3 | 2017-04-06 | French | Compare |
v4 | 2017-04-10 | English | Compare |
v5 | 2017-04-10 | English | Compare |
v6 | 2017-04-10 | English | Compare |
v7 | 2017-04-10 | French | Compare |
v8 | 2017-04-25 | English | Compare |
v9 | 2017-04-26 | English | Compare |
v10 | 2017-04-26 | French | Compare |
v11 | 2017-04-26 | English | Compare |
v12 | 2017-04-26 | English | Compare |
v13 | 2017-04-26 | French | Compare |
v14 | 2017-04-27 | English | Compare |
Showing 1 to 14 of 14